Evidence map›Paper›PMID 40708439›Full record

ArticleChemistry (Weinheim an der Bergstrasse, Germany)2025

Engineering Alloxazines by Boron Coordination and Click Chemistry toward Small-molecule Fluorescent Probes.

Oscar Charpentier, Ambroise Mouhanna, Eleanna Nikolopoulos, Aurélie Guenet, Christophe Gourlaouen, Marine Desage-El Murr

Abstract read
In one paragraph

Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Oscar CharpentierCNRS UMR7177, Université de Strasbourg, Institut de Chimie, 4, rue Blaise Pascal, Strasbourg, 67000, France.ORCID https://orcid.org/0009-0009-0463-4952
Ambroise MouhannaCNRS UMR7177, Université de Strasbourg, Institut de Chimie, 4, rue Blaise Pascal, Strasbourg, 67000, France.ORCID https://orcid.org/0009-0003-3975-845X
Eleanna NikolopoulosCNRS UMR7177, Université de Strasbourg, Institut de Chimie, 4, rue Blaise Pascal, Strasbourg, 67000, France.
Aurélie GuenetCNRS UMR7177, Université de Strasbourg, Institut de Chimie, 4, rue Blaise Pascal, Strasbourg, 67000, France.ORCID https://orcid.org/0000-0001-6265-6767
Christophe GourlaouenCNRS UMR7140, Université de Strasbourg, CMC, 4, rue Blaise Pascal, Strasbourg, 67000, France.ORCID https://orcid.org/0000-0002-2409-2849
Marine Desage-El MurrCNRS UMR7177, Université de Strasbourg, Institut de Chimie, 4, rue Blaise Pascal, Strasbourg, 67000, France.ORCID https://orcid.org/0000-0001-5017-4496

Funding

Agence Nationale de la Recherche ANR-18-CE092-0040-01Agence Nationale de la Recherche ANR-20-CE05-0005-01
6 · The paper itself

Abstract

Selective and strategic modification of redox cofactors offers significant advantages for the design of molecular probes, including high compatibility and affinity. This is particularly relevant in the case of redox cofactors with innate fluorescence properties, such as flavins, and synthetic strategies toward their functionalized analogues are of high interest to modulate properties. However, the synthetic elaboration of flavins and their alloxazine isomers still suffers from limitations. We report easy access to bioinspired fluorescent alloxazines with a boron difluorocatecholate moiety and explore the impact of core aromatic substitution on their photophysical properties. Further chemical elaboration through a CuAAC (copper-catalyzed azide-alkyne cycloaddition) click chemistry strategy opens the way to easy derivatization and further addressing.

Indexed as

alloxazineboroncatecholflavinnoncanonical redox cofactors

Identifiers

PMID40708439
PMCPMC12376245

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.